SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 184.82-2.0%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (16812)3/8/1998 9:06:00 PM
From: Flagrante Delictu  Read Replies (2) of 32384
 
Henry, Re: H & Q conference this Jan. & the SBH product. My notes are equivocal as to whether they are bringing both EPO & G-CSF to trials this year or just bringing one of them. They are working on both with SBH. They said they expected a drug on the market, from the collaboration, in 2005. Unfortunately, I cannot recall now which is expected first.
However, I did notice that Greg U. reported that a perusal of medsunman's notes seemed to indicate a STATs product would be available by 2005. Maybe he can provide the reference to it to help clear it up. Vector1 was also in attendance. Maybe, he or medsunman can elaborate.
My notes read, " With SKline - oral EPO & GCSF- {SKB} extended the timeframe { of the collaboration}- drug in 2005".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext